17-(1'propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

A 17-(1′-Propenyl)-17-3′-oxidoestra-4-en-3-one derivative with the general chemical formula I

• in which
• Z is selected from the group comprising oxygen, two hydrogen atoms, NOR′ or NNHSO2R′, where R′ is hydrogen, C1-C10-alkyl, aryl and C7-C20-aralkyl,
• R4 is selected from the group comprising hydrogen and halogen,
• furthermore either:
• R6a, R6b each independently of one another are selected from the group comprising hydrogen, C1-C10-alkyl, C2-C10-alkenyl and C2-C10-alkynyl or together form methylene or 1,2-ethanediyl and
• R7 is selected from the group comprising hydrogen, C1-C10-alkyl, C3-C6-cycloalkyl, C2-C10-alkenyl and C2-C10-alkynyl,
• or:
• R6a, R7 together form oxygen or a methylene group or drop out with formation of a double bond between C6 and C7 and
• R6b is selected from the group comprising hydrogen, C1-C10-alkyl, C2-C10-alkenyl and C2-C10-alkynyl,
• furthermore either:
• R15 is hydrogen and
• R16a, R16b together form methylene or 1,2-ethanediyl or, each independently of one another, are selected from the group comprising hydrogen and C1-C10-alkyl,
• or:
• R15, R16a together form oxygen or drop out with formation of a double bond between C15 and C16 and
• R16b is selected from the group comprising hydrogen and C1-C10-alkyl and
• R18 is selected from the group comprising hydrogen and C1-C3-alkyl,
• and its solvates, hydrates and salts and including all stereoisomers.